Skip to main content
ACADIA Pharmaceuticals Inc. (ACAD)
NASDAQ: ACAD · Real-Time Price · USD
14.83
+0.21 (1.44%)
Apr 24, 2025, 4:00 PM EDT - Market closed

ACADIA Pharmaceuticals Revenue by Product
Period Ending Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022Mar 31, 2022Dec 31, 2021Sep 30, 2021Jun 30, 2021Mar 31, 2021Dec 31, 2020
NUPLAZID
609.42M 590.42M 576.06M 560.67M 549.21M 541.81M 527.68M 520.26M
NUPLAZID Growth
10.96% 8.97% 9.17% 7.77% 6.17% 5.90% 2.96% 5.51%
DAYBUE
348.38M 338.78M 314.43M 253.10M 177.19M 90.09M 23.22M -
DAYBUE Growth
96.61% 276.05% 1,254.32% - - - - -
Source: Business metrics provided by Main Street Data and sourced from official company press releases and documents.